Home
Insights
Dashboard
EU Projects
Companies
European Innovation Council
Funding
Corporates
Universities
Resources
Companies
Affect Therapeutics
Save
Affect Therapeutics
Using mobile technology to deliver the world's first evidence-based, substance-specific recovery program for methamphetamine and cocaine use disorder.
Overview
Similar companies
Analytics
Notes
Job openings
Innovations (0)
Recent News about Affect Therapeutics
Edit